High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.
combined with EBRT
high-dose-rate
interstitial brachytherapy
monotherapy
prostate cancer
salvage
Journal
Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
10
05
2021
received:
13
12
2020
accepted:
12
05
2021
pubmed:
25
6
2021
medline:
25
3
2022
entrez:
24
6
2021
Statut:
ppublish
Résumé
High-dose-rate brachytherapy (HDR BRT) has been enjoying rapid acceptance as a treatment modality offered to selected prostate cancer patients devoid of risk group, employed either in monotherapy setting or combined with external beam radiation therapy (EBRT) and is currently one of the most active clinical research areas. This review encompasses all the current evidence to support the use of HDR BRT in various clinical scenario and shines light to the HDR BRT rationale, as an ultimately conformal dose delivery method enabling safe dose escalation to the prostate. Valid long-term data, both in regard to the oncologic outcomes and toxicity profile, support the current clinical indication spectrum of HDR BRT. At the same time, this serves as solid, rigid ground for emerging therapeutic applications, allowing the technique to remain in the spotlight alongside stereotactic radiosurgery.
Sections du résumé
BACKGROUND
High-dose-rate brachytherapy (HDR BRT) has been enjoying rapid acceptance as a treatment modality offered to selected prostate cancer patients devoid of risk group, employed either in monotherapy setting or combined with external beam radiation therapy (EBRT) and is currently one of the most active clinical research areas.
RECENT FINDINGS
This review encompasses all the current evidence to support the use of HDR BRT in various clinical scenario and shines light to the HDR BRT rationale, as an ultimately conformal dose delivery method enabling safe dose escalation to the prostate.
CONCLUSION
Valid long-term data, both in regard to the oncologic outcomes and toxicity profile, support the current clinical indication spectrum of HDR BRT. At the same time, this serves as solid, rigid ground for emerging therapeutic applications, allowing the technique to remain in the spotlight alongside stereotactic radiosurgery.
Identifiants
pubmed: 34164950
doi: 10.1002/cnr2.1450
pmc: PMC8789612
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1450Informations de copyright
© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.
Références
Front Oncol. 2014 Nov 24;4:321
pubmed: 25505732
Radiother Oncol. 2011 Feb;98(2):169-74
pubmed: 21296444
Radiat Oncol. 2015 Nov 14;10:228
pubmed: 26577301
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1949-56
pubmed: 21763081
Radiother Oncol. 2008 Jul;88(1):46-52
pubmed: 18378028
Brachytherapy. 2006 Jul-Sep;5(3):157-64
pubmed: 16864067
Eur Urol. 2005 Apr;47(4):441-8
pubmed: 15774239
Radiat Oncol. 2008 May 21;3:15
pubmed: 18495016
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-33
pubmed: 17084558
Brachytherapy. 2008 Jul-Sep;7(3):231-6
pubmed: 18579446
Radiother Oncol. 2017 Jul;124(1):56-60
pubmed: 28666552
Radiother Oncol. 2004 Apr;71(1):23-8
pubmed: 15066292
BJU Int. 2012 Feb;109 Suppl 1:17-21
pubmed: 22239225
Theranostics. 2017 Jan 1;7(1):228-237
pubmed: 28042330
Nihon Hinyokika Gakkai Zasshi. 2011 Jul;102(4):621-7
pubmed: 21961274
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1889-96
pubmed: 21550182
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1376-84
pubmed: 21680108
J Contemp Brachytherapy. 2017 Aug;9(4):383-389
pubmed: 28951759
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1043-8
pubmed: 18755555
Adv Radiat Oncol. 2019 Apr 18;4(4):631-640
pubmed: 31673656
J Nucl Med. 2016 Nov;57(11):1720-1725
pubmed: 27261520
J Urol. 2005 May;173(5):1562-6
pubmed: 15821486
Brachytherapy. 2015 May-Jun;14(3):359-65
pubmed: 25736733
Radiat Oncol. 2014 Apr 30;9:102
pubmed: 24885287
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285
pubmed: 28262473
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):561-567
pubmed: 30244878
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1064-71
pubmed: 20584576
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):657-66
pubmed: 26797541
Strahlenther Onkol. 2014 Feb;190(2):165-70
pubmed: 24317192
Cancers (Basel). 2011 Sep 14;3(3):3585-600
pubmed: 24212968
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105
pubmed: 12128107
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):777-87
pubmed: 15465194
World J Urol. 2006 Aug;24(3):289-95
pubmed: 16645877
Brachytherapy. 2010 Jan-Mar;9(1):15-22
pubmed: 19734106
J Urol. 2007 Nov;178(5):1963-7
pubmed: 17868718
J Urol. 2003 Mar;169(3):974-9; discussion 979-80
pubmed: 12576825
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52
pubmed: 10802358
Urology. 2014 Jan;83(1):181-5
pubmed: 24139351
Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):81-90
pubmed: 11777625
Cancer Rep (Hoboken). 2022 Jan;5(1):e1450
pubmed: 34164950
Radiother Oncol. 2017 Jul;124(1):49-55
pubmed: 28652094
Radiother Oncol. 2018 Aug;128(2):301-307
pubmed: 29764692
Int J Med Sci. 2008 Jun 04;5(3):113-20
pubmed: 18566673
Expert Rev Anticancer Ther. 2009 Jan;9(1):61-5
pubmed: 19105707
Brachytherapy. 2010 Oct-Dec;9(4):313-8
pubmed: 20685176
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):811-7
pubmed: 19836166
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8
pubmed: 10705005
J Urol. 2005 Sep;174(3):882-7
pubmed: 16093980
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):543-8
pubmed: 22652111
Eur Urol. 2012 Jun;61(6):1204-11
pubmed: 22421081
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):363-70
pubmed: 21195875
Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):6-13
pubmed: 11777617
Eur Urol. 2017 May;71(5):766-773
pubmed: 27452951
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):269-76
pubmed: 19775833
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74
pubmed: 16798415
J Urol. 2004 Mar;171(3):1098-104
pubmed: 14767279
Cancer. 2012 Aug 1;118(15):3681-90
pubmed: 22170628
Clin Oncol (R Coll Radiol). 2013 Aug;25(8):474-82
pubmed: 23727431
Pract Radiat Oncol. 2015 Nov-Dec;5(6):e615-23
pubmed: 26059509
Brachytherapy. 2014 Nov-Dec;13(6):529-41
pubmed: 25085454
J Radiat Res. 2013 Sep;54(5):781-8
pubmed: 23543798
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):675-82
pubmed: 26238951
J Contemp Brachytherapy. 2010 Sep;2(3):117-128
pubmed: 27853473
Radiother Oncol. 2016 Jun;119(3):411-6
pubmed: 27118583
J Endourol. 2010 May;24(5):865-9
pubmed: 20433370
J Clin Oncol. 2006 May 1;24(13):1990-6
pubmed: 16648499
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16
pubmed: 15817332
J Nucl Med. 2018 Jul 12;60(2):227-233
pubmed: 30002108
Brachytherapy. 2013 Sep-Oct;12(5):428-33
pubmed: 23622710
JAMA. 1998 Sep 16;280(11):969-74
pubmed: 9749478
BJU Int. 2012 Mar;109(6):835-9
pubmed: 21933327
Eur Urol. 2014 Jan;65(1):124-37
pubmed: 24207135
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):416-23
pubmed: 16879929
Brachytherapy. 2017 Sep - Oct;16(5):993-999
pubmed: 28754301
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1028-33
pubmed: 18280056
BJU Int. 2017 Jun;119(6):896-904
pubmed: 28063191
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):877-82
pubmed: 21300474
Radiother Oncol. 2016 Jun;119(3):405-10
pubmed: 27165612
Lancet Oncol. 2019 Nov;20(11):1531-1543
pubmed: 31540791
Radiat Oncol. 2011 Jan 10;6:3
pubmed: 21219625
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e17-24
pubmed: 21324610
J Contemp Brachytherapy. 2019 Oct;11(5):399-408
pubmed: 31749847
Am J Clin Oncol. 2009 Apr;32(2):187-90
pubmed: 19307949
Brachytherapy. 2012 Jan-Feb;11(1):20-32
pubmed: 22265435
J Natl Compr Canc Netw. 2019 May 1;17(5.5):583-586
pubmed: 31117038
Cancer. 2002 Jul 15;95(2):281-6
pubmed: 12124827
Brachytherapy. 2014 Mar-Apr;13(2):111-6
pubmed: 24373762
Radiother Oncol. 2004 Apr;71(1):35-41
pubmed: 15066294
Med Phys. 2011 Sep;38(9):4982-93
pubmed: 21978042
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):98-106
pubmed: 27979460
Am J Clin Oncol. 2014 Jun;37(3):297-304
pubmed: 22706173
Radiat Oncol. 2012 Mar 07;7:31
pubmed: 22397528
Brachytherapy. 2018 Nov - Dec;17(6):845-851
pubmed: 30030111
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1038-1044
pubmed: 30771408
Br J Radiol. 2012 Nov;85 Spec No 1:S18-27
pubmed: 23118099
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):16-22
pubmed: 17996382
Am J Clin Oncol. 2010 Oct;33(5):481-8
pubmed: 19952715
Med Dosim. 2013 Winter;38(4):385-9
pubmed: 23809693
Transl Androl Urol. 2018 Jun;7(3):414-435
pubmed: 30050801
Radiother Oncol. 2015 Apr;115(1):84-9
pubmed: 25770875
Jpn J Clin Oncol. 2010 Dec;40(12):1159-65
pubmed: 20630898
J Contemp Brachytherapy. 2009 Jun;1(2):105-108
pubmed: 27795720
Radiother Oncol. 2012 May;103(2):217-22
pubmed: 22341794
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):693-702
pubmed: 32092343
Radiother Oncol. 2005 Feb;74(2):157-61
pubmed: 15734203
JAMA. 1999 May 5;281(17):1591-7
pubmed: 10235151
Radiother Oncol. 2014 Dec;113(3):410-3
pubmed: 25544648
Radiat Oncol. 2014 May 28;9:122
pubmed: 24885327
Eur Urol. 2011 Dec;60(6):1133-9
pubmed: 21889832
J Clin Oncol. 2010 Mar 1;28(7):1106-11
pubmed: 20124169
Int J Urol. 2013 Feb;20(2):185-92
pubmed: 22905941
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):324-9
pubmed: 23474112
Front Radiat Ther Oncol. 2011;43:344-368
pubmed: 21625162
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):38-47
pubmed: 16904516
Brachytherapy. 2015 May-Jun;14(3):366-72
pubmed: 25680768
Nat Clin Pract Oncol. 2007 Nov;4(11):632-42
pubmed: 17965641
Cancer. 2013 Sep 15;119(18):3265-71
pubmed: 23798338
Brachytherapy. 2017 May - Jun;16(3):503-510
pubmed: 28222973
Radiat Oncol. 2013 May 08;8:115
pubmed: 23656899
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1035-41
pubmed: 9169810
Med Phys. 2012 Jun;39(6):3291-8
pubmed: 22755712
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):469-75
pubmed: 20646858
Cancer J. 2009 Jan-Feb;15(1):1-6
pubmed: 19197165
J Clin Oncol. 2005 Feb 20;23(6):1192-9
pubmed: 15718316
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):400-7
pubmed: 22019244
Med Phys. 2009 Nov;36(11):5310-22
pubmed: 19994539
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):667-74
pubmed: 26443877
J Urol. 2008 Apr;179(4):1368-73; discussion 1373
pubmed: 18289585
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1106-12
pubmed: 17197119
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1286-92
pubmed: 21310546
Technol Cancer Res Treat. 2009 Jun;8(3):201-6
pubmed: 19445537
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):61-9
pubmed: 11163498
Brachytherapy. 2013 Jan-Feb;12(1):44-9
pubmed: 22831750
Lancet Oncol. 2007 Jun;8(6):475-87
pubmed: 17482880
J Urol. 2012 Jan;187(1):109-16
pubmed: 22088340
Int Urol Nephrol. 2013 Feb;45(1):113-9
pubmed: 22972569
Radiother Oncol. 2013 Jun;107(3):325-32
pubmed: 23773409
Eur J Cancer. 2012 Jul;48(11):1664-71
pubmed: 22336663
Strahlenther Onkol. 2006 Mar;182(3):135-41
pubmed: 16520907
Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):491-500
pubmed: 9635694
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):90-93
pubmed: 28816169
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):286-295
pubmed: 28433432
Asian J Androl. 2015 Nov-Dec;17(6):899-903
pubmed: 26112477
Br J Radiol. 1989 Aug;62(740):679-94
pubmed: 2670032
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74
pubmed: 17765406
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):316-27
pubmed: 12023135
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):600-5
pubmed: 21377288
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):672-8
pubmed: 22929859
Brachytherapy. 2017 Jan - Feb;16(1):186-192
pubmed: 28341011
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):927-32
pubmed: 22197086
Brachytherapy. 2016 Nov - Dec;15(6):722-729
pubmed: 27693225
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1048-55
pubmed: 15001244
Radiother Oncol. 2020 May;146:90-96
pubmed: 32146259
Eur Urol. 2012 May;61(5):961-71
pubmed: 22280856
Med Dosim. 2012 Winter;37(4):406-11
pubmed: 22534138
Brachytherapy. 2011 Sep-Oct;10(5):376-84
pubmed: 21345741
J Urol. 2007 Jan;177(1):123-7; discussion 127
pubmed: 17162020
Radiother Oncol. 2018 Feb;126(2):270-277
pubmed: 29074079
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):684-90
pubmed: 15183471
Curr Probl Cancer. 2008 Nov-Dec;32(6):242-71
pubmed: 19064119
Radiother Oncol. 2011 Apr;99(1):37-43
pubmed: 21458092
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31
pubmed: 16029788
Clin Adv Hematol Oncol. 2012 Nov;10(11):716-22
pubmed: 23271258